Treatment for Mild Symptoms of Shoulder-Hand Syndrome
Initial Non-Pharmacological Approaches
- Active, active-assisted, or passive range of motion exercises should be implemented immediately as both treatment and prevention for shoulder-hand syndrome, focusing on gentle stretching and mobilization techniques, as recommended by the American Heart Association 1, 2
- Exercises should emphasize increasing external rotation and abduction of the shoulder, gradually restoring alignment and strengthening weak muscles in the shoulder girdle, with a strength of evidence level of moderate 2
- Education concerning joint protection and ergonomic principles should be provided to help patients avoid adverse mechanical factors, according to the European League Against Rheumatism 4, 5
- Local application of heat (e.g., paraffin wax, hot packs) before exercise can provide symptomatic relief, with a low risk of adverse effects 6
- For thumb base involvement, splints and orthoses should be considered for symptom relief, as suggested by the European League Against Rheumatism 4, 5
Pharmacological Management
First-Line Treatment
- Topical treatments are preferred over systemic treatments due to safety considerations, especially for mild to moderate pain, as recommended by the European League Against Rheumatism 4, 5
- Topical NSAIDs should be the first pharmacological treatment of choice, with a high strength of evidence 4, 5
- Topical capsaicin may also be effective and safe for hand involvement, with a moderate strength of evidence 6
Second-Line Treatment
- If topical treatments are insufficient, acetaminophen (up to 4 g/day) should be used as the first-choice oral analgesic due to its efficacy and safety profile, as recommended by the European League Against Rheumatism 6
- For continued symptoms, oral NSAIDs may be used at the lowest effective dose and for the shortest duration in patients who respond inadequately to acetaminophen, with a moderate strength of evidence 6, 4
- In patients with increased gastrointestinal risk, either non-selective NSAIDs with a gastroprotective agent or a selective COX-2 inhibitor should be used, as suggested by the European League Against Rheumatism 6
- In patients with increased cardiovascular risk, COX-2 inhibitors are contraindicated and non-selective NSAIDs should be used with caution, with a high strength of evidence 6
For Persistent or Progressive Symptoms
- If symptoms persist despite initial management, an early course of oral corticosteroids may be considered, starting at 30-50 mg daily for 3-5 days, then tapering over 1-2 weeks, as recommended by the American Heart Association 2, 3
- For shoulder pain related to spasticity, injections of botulinum toxin into the subscapularis and pectoralis muscles could be considered, with a moderate strength of evidence 2, 7
- When pain is related to inflammation of the subacromial region, subacromial corticosteroid injections may be used, as suggested by the American Heart Association 2
Monitoring and Follow-up
- Patients should be reassessed periodically to evaluate their response to treatment, as recommended by the European League Against Rheumatism 6
- Long-term follow-up should be adapted to the patient's individual needs, with a moderate strength of evidence 4, 5
- Avoid overhead pulley exercises as they may exacerbate symptoms, with a low risk of adverse effects 7
- Triple-phase bone scan can assist in diagnosis when clinical presentation is unclear, as suggested by the American Heart Association 2, 3